Genetica, Asia’s foremost AI genetic testing firm, officially launches its DeSci GenomicDAO platform to accelerate the improvement and advancement of precision medication. ).
With 3 technologies pillars namely Artificial Intelligence (AI), Asian-unique Gene Decoding Chip, and Blockchain, Genetics and GenomicDAO’s objective is to support hundreds of thousands of consumers proactively steer their long term healthcare.
Precision medication (Source: genetics) is an ground breaking strategy to disorder prevention and remedy that considers human genetics, the atmosphere and life style. The international precision medication market place dimension is valued at USD 66.one billion in 2021 and is projected to attain USD 175.64 billion by 2030 (Source: Precedence search).
The discipline is projected to develop at a compound yearly development price (CAGR) of eleven.five% in between 2022 and 2030, driven by advances in cancer biology, improved adoption of gene treatment globally, from the improved use of large information analytics in precision medication in produced nations, and patient engagement in customized healthcare.
Founded in 2015, in a single of the quickest expanding markets for precision medication, Asia, Genetica has been an sector leader with more than a hundred,000 client genetic profiles as a result of its proprietary genetic code interpretation support.
GenomicDAO | Decentralized Autonomous Organization (DAO)
GenomicDAO goes past the recent health-related study and improvement market place by constructing a local community that will initiate and drive precision medication tasks.
Community members can contribute sources to the frequent objective of GenomicDAO, by contributing their personal capital or genetic information, therefore reaping each economic and health-related rewards from foremost health-related tasks.
Market | Centralized market place for genetic merchandise
GenomicDAO’s greatest objective is to produce merchandise that operate to fix local community-initiated wellbeing difficulties. GenomicDAO will manufacture and personal proprietary genomic merchandise this kind of as genetic info, customized wellbeing care and disorder prevention suggestions, and customized medication.
The GenomicDAO platform will serve as a springboard to assistance and encourage a variety of precision medication tasks and a separate DAO for just about every.
To obtain its grand objectives, GenomicDAO is created on a powerful basis consisting of proprietary technologies in collaboration with foremost genomics organizations, led by foremost biotech gurus and an specialist advisory board in each the regular and blockchain markets.
GenomicDAO’s income comes from customer genetic merchandise. The income is then employed to acquire back tokens, escalating the capitalization of the venture and benefiting traders.
Outstanding success of genetics – Parent firm of GenomicDAO:
- Strategic partnership with Illumina® and Thermo Fisher, two of the world’s foremost genomics organizations
- Catalog with much more than twenty+ diversified merchandise based mostly on consumer requires from intensive wellbeing care, disorder prevention, nutrition, sports activities, early detection of disorder dangers (this kind of as stroke, allergy symptoms, diabetes, and so on.) sugar, cancer,.. )
- Accuracy up to 99.9% in accordance to US technologies specifications
- Prize: Global Health & Pharma Magazine’s Top AI Genetic Testing Company
- The staff of specialist consultants are best scientists from planet-renowned universities this kind of as UCSF, Harvard, Stanford, Cornell.
GenomicDAO kicks off its initially venture: Stroke Prevention with Stroke-PreventionDAO will officially launch the PCSP token on February 20th.
PCSP tokens
PCSP is a utility and governance token in the Genomic DAO ecosystem.
Detailed Tokenomics: https://docs.genomicdao.com/genomicdao-whitepaper/token-economy
About the PCSP Token:
- Token Name: GenomicDAO stroke prevention token
- Token symbol: PCSP
- Network: BEP-twenty
- Total provide: one,000,000,000
- Sale to the public: N/A
Allocation of tokens
- Community Development: a hundred,000,000
- Developer Endowment: a hundred,000,000
- Strategic Partners: 50,000,000
- Liquidity: 50,000,000
- Team: a hundred,000,000
- Consultant: 50,000,000
- Research and improvement: 150,000,000
- Reserved for the following evolution of GenomicDAO: a hundred,000,000
- GenomicDAO Launchpad: 300,000,000
Media channel:
Genomic DAO website | Facebook | Chirping | Telegram channel | Genetics site
